Survival effects of neurological and psychiatric co-medications in Liver Transplant patients

Abstract

Background: Liver transplantation (LT) is the only curative option in patients with end-stage liver disease. Due to significant development in the field, most post-transplant morbidity and mortality are increasingly associated with factors other than the transplantation itself. However, liver transplantation has been more frequently associated with neurological disorders when compared to other solid organ transplants, and higher rates of psychiatric disorders are reported among cirrhotic patients. Therefore, we aimed to assess the neurological and psychiatric co-medications in post-liver transplant patients and their impact on overall survival.